⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 29, 2024Future OncologyOpen Access

OCEANIA: real-world study of ovarian cancer treatment patterns across multiple lines of therapy in Argentina and Brazil

Cláudia Soares Gabriela de Azevedo Abreu Thiago Luiz Nogueira da Silva Juliana Queiroz Patricia Candida de Menezes Graziela Bernardino Tânia C. S. P. Pires Mariano Carrizo Rosana Felice M.C. Riggi Florencia Cravero André Luiz Alves Ribeiro de Souza Laura Jotimliansky

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate real-world data on treatment patterns in Argentina and Brazil in patients with ovarian cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Soares et al. (2024) studied this question.

synapsesocial.com/papers/68e67f77b6db6435876093f0 https://doi.org/10.1080/14796694.2024.2343650

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ovarian cancer in Portugal: a real-world evidence reviewReview · 2026
2Clinical and outcome patterns in epithelial ovarian cancer (EOC) within a Latin American cohort.2024 · 1 citations
31019 Country differences in physician’s biomarker testing patterns and treatment in advanced ovarian cancer: analysis of the adelphi real world disease specific programme (DSP™)2024
4Endometrial cancer treatment and outcomes in Argentina: ECHOS-A real-world study2024 · 1 citations
572P Real-world data of treatment and outcome of patients with advanced ovarian cancer (AOC) in Germany: QS OVAR of the AGO Study Group2024

The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer2024
Abstract PO1-16-06: LuciA-15 - A real-world prospective study of PARP inhibitors for the treatment of Latin American patients with HER-2 negative metastatic breast cancer with mutation of BRCA1/2 genes or in the Homologous Recombination Repair genes2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe2024
Protocol for a multicenter prospective phase II trial of adjuvant tislelizumab combined with S-1 in subjects with residual primary lesions and node-negative esophageal squamous cell carcinoma (PPIO-008)Future Oncology · 2026
Phase 1 study of OX40 agonist ABBV-368 as monotherapy or in combination with budigalimab in advanced solid tumorsFuture Oncology · 2026

More from Future Oncology

More from Hospital Italiano de Buenos Aires

More from GlaxoSmithKline (Brazil)